Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UnitedHealth Group Inc (UNH) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance

UnitedHealth Group IncTrade
Direxion Daily FTSE China Bull 3x SharesTrade

Price performance (Past 24H)

Key statistics

UnitedHealth Group Inc vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? UnitedHealth Group Inc trades at $379.3 (market cap $332.96B), while Direxion Daily FTSE China Bull 3x Shares trades at $25.27 (market cap $560.32M). The key difference: UnitedHealth Group Inc is far larger — about 594.2× Direxion Daily FTSE China Bull 3x Shares's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Direxion Daily FTSE China Bull 3x Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 97 Days and Direxion Daily FTSE China Bull 3x Shares for 25 Days on average.

UNHYINN
Market Cap
$332.96B$560.32M
Volume
7,273,7491,009,521
Sector
HealthLeveraged / Inverse
52-Week High
$436.35$52.69
52-Week Low
$259.02$21.45
Typical Hold Time
97 Days25 Days
Enterprise Value
$374.82B—
Dividend Yield
2.5%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

Direxion Daily FTSE China Bull 3x Shares

YINN trades at $23.63, up 0.3% with a bearish technical outlook showing 17 sell signals versus 2 buy signals. Moving averages indicate strong bearish momentum while oscillators remain neutral. The stock faces resistance at $24 with support at $23. Recent news highlights China's economic policies affecting Asian markets, though YINN's specific fundamentals show limited available data.

The bearish technical setup and lack of clear fundamental metrics create uncertainty. Investment opportunity depends on broader market trends and China's economic developments, while risks include technical breakdown below support and regional economic volatility. Further fundamental disclosure is needed for comprehensive analysis.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UNH
71% Buy29% Sell
Avg holding period · 97 Days
YINN
100% Buy0% Sell
Avg holding period · 25 Days

Top news

Latest headlines on both assets

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →

About Direxion Daily FTSE China Bull 3x Shares

YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.

Read more on YINN →